Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
DUBA: A Deubiquitinase That Regulates Type I Interferon Production
Nobuhiko Kayagaki,1
Qui Phung,2
Salina Chan,1
Ruchir Chaudhari,1
Casey Quan,1
Karen M. O'Rourke,1
Michael Eby,1
Eric Pietras,3
Genhong Cheng,3
J. Fernando Bazan,4
Zemin Zhang,5
David Arnott,2
Vishva M. Dixit1*
Abstract:
Production of type I interferon (IFN-I) is a critical host defensetriggered by pattern-recognition receptors (PRRs) of the innateimmune system. Deubiquitinating enzyme A (DUBA), an ovariantumor domain-containing deubiquitinating enzyme, was discoveredin a small interfering RNA–based screen as a regulatorof IFN-I production. Reduction of DUBA augmented the PRR-inducedIFN-I response, whereas ectopic expression of DUBA had the converseeffect. DUBA bound tumor necrosis factor receptor–associatedfactor 3 (TRAF3), an adaptor protein essential for the IFN-Iresponse. TRAF3 is an E3 ubiquitin ligase that preferentiallyassembled lysine-63–linked polyubiquitin chains. DUBAselectively cleaved the lysine-63–linked polyubiquitinchains on TRAF3, resulting in its dissociation from the downstreamsignaling complex containing TANK-binding kinase 1. A discreteubiquitin interaction motif within DUBA was required for efficientdeubiquitination of TRAF3 and optimal suppression of IFN-I.Our data identify DUBA as a negative regulator of innate immuneresponses.
1 Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA. 2 Department of Protein Chemistry, Genentech, South San Francisco, CA 94080, USA. 3 Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA 90095, USA. 4 Department of Protein Engineering, Genentech, South San Francisco, CA 94080, USA. 5 Department of Bioinformatics, Genentech, South San Francisco, CA 94080, USA.
* To whom correspondence should be addressed. E-mail: dixit{at}gene.com
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (11 December 2007) Sci. STKE2007 (416), tw452.
[DOI: 10.1126/stke.4162007tw452] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Ubiquitin-Specific Protease 25 Regulates TLR4-Dependent Innate Immune Responses Through Deubiquitination of the Adaptor Protein TRAF3.
B. Zhong, X. Liu, X. Wang, X. Liu, H. Li, B. G. Darnay, X. Lin, S.-C. Sun, and C. Dong (2013)
Science Signaling
6, ra35
|Abstract »|Full Text »|PDF »
Recognition of pathogen-associated nucleic acids by endosomal nucleic acid-sensing toll-like receptors.
X. He, H. Jia, Z. Jing, and D. Liu (2013)
Acta Biochim Biophys Sin
45, 241-258
|Abstract »|Full Text »|PDF »
Epstein-Barr Virus Deubiquitinase Downregulates TRAF6-Mediated NF-{kappa}B Signaling during Productive Replication.
S. Saito, T. Murata, T. Kanda, H. Isomura, Y. Narita, A. Sugimoto, D. Kawashima, and T. Tsurumi (2013)
J. Virol.
87, 4060-4070
|Abstract »|Full Text »|PDF »
Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.
P. B. van Kasteren, B. A. Bailey-Elkin, T. W. James, D. K. Ninaber, C. Beugeling, M. Khajehpour, E. J. Snijder, B. L. Mark, and M. Kikkert (2013)
PNAS
110, E838-E847
|Abstract »|Full Text »|PDF »
The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane.
H. Tanno, T. Yamaguchi, E. Goto, S. Ishido, and M. Komada (2012)
Mol. Biol. Cell
23, 1343-1353
|Abstract »|Full Text »|PDF »
Emerging Role of Ubiquitination in Antiviral RIG-I Signaling.
Arterivirus and Nairovirus Ovarian Tumor Domain-Containing Deubiquitinases Target Activated RIG-I To Control Innate Immune Signaling.
P. B. van Kasteren, C. Beugeling, D. K. Ninaber, N. Frias-Staheli, S. van Boheemen, A. Garcia-Sastre, E. J. Snijder, and M. Kikkert (2012)
J. Virol.
86, 773-785
|Abstract »|Full Text »|PDF »
MIP-T3 Is a Negative Regulator of Innate Type I IFN Response.
M.-H. J. Ng, T.-H. Ho, K.-H. Kok, K.-L. Siu, J. Li, and D.-Y. Jin (2011)
J. Immunol.
187, 6473-6482
|Abstract »|Full Text »|PDF »
ABIN1 Protein Cooperates with TAX1BP1 and A20 Proteins to Inhibit Antiviral Signaling.
L. Gao, H. Coope, S. Grant, A. Ma, S. C. Ley, and E. W. Harhaj (2011)
J. Biol. Chem.
286, 36592-36602
|Abstract »|Full Text »|PDF »
SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
Y. Ran, T.-T. Liu, Q. Zhou, S. Li, A.-P. Mao, Y. Li, L.-J. Liu, J.-K. Cheng, and H.-B. Shu (2011)
J Mol Cell Biol
3, 283-292
|Abstract »|Full Text »|PDF »
Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis.
M.-J. Bijlmakers, S. K. Kanneganti, J. N. Barker, R. C. Trembath, and F. Capon (2011)
Hum. Mol. Genet.
20, 3129-3137
|Abstract »|Full Text »|PDF »
The Leader Proteinase of Foot-and-Mouth Disease Virus Negatively Regulates the Type I Interferon Pathway by Acting as a Viral Deubiquitinase.
D. Wang, L. Fang, P. Li, L. Sun, J. Fan, Q. Zhang, R. Luo, X. Liu, K. Li, H. Chen, et al. (2011)
J. Virol.
85, 3758-3766
|Abstract »|Full Text »|PDF »
Structural Analysis of a Viral Ovarian Tumor Domain Protease from the Crimean-Congo Hemorrhagic Fever Virus in Complex with Covalently Bonded Ubiquitin.
G. C. Capodagli, M. A. McKercher, E. A. Baker, E. M. Masters, J. S. Brunzelle, and S. D. Pegan (2011)
J. Virol.
85, 3621-3630
|Abstract »|Full Text »|PDF »
ARF-like Protein 16 (ARL16) Inhibits RIG-I by Binding with Its C-terminal Domain in a GTP-dependent Manner.
Y.-K. Yang, H. Qu, D. Gao, W. Di, H.-W. Chen, X. Guo, Z.-H. Zhai, and D.-Y. Chen (2011)
J. Biol. Chem.
286, 10568-10580
|Abstract »|Full Text »|PDF »
Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease.
T. W. James, N. Frias-Staheli, J.-P. Bacik, J. M. Levingston Macleod, M. Khajehpour, A. Garcia-Sastre, and B. L. Mark (2011)
PNAS
108, 2222-2227
|Abstract »|Full Text »|PDF »
Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains.
M. Akutsu, Y. Ye, S. Virdee, J. W. Chin, and D. Komander (2011)
PNAS
108, 2228-2233
|Abstract »|Full Text »|PDF »
TNF Receptor-Associated Factor 3 Is Required for T Cell-Mediated Immunity and TCR/CD28 Signaling.
P. Xie, Z. J. Kraus, L. L. Stunz, Y. Liu, and G. A. Bishop (2011)
J. Immunol.
186, 143-155
|Abstract »|Full Text »|PDF »
J. M. Gonzalez-Navajas, J. Law, K. P. Nguyen, M. Bhargava, M. P. Corr, N. Varki, L. Eckmann, H. M. Hoffman, J. Lee, and E. Raz (2010)
J. Exp. Med.
207, 2799-2807
|Abstract »|Full Text »|PDF »
MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-{kappa}B signaling.
J. Liang, Y. Saad, T. Lei, J. Wang, D. Qi, Q. Yang, P. E. Kolattukudy, and M. Fu (2010)
J. Exp. Med.
207, 2959-2973
|Abstract »|Full Text »|PDF »
Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis.
V. Kapuria, L. F. Peterson, D. Fang, W. G. Bornmann, M. Talpaz, and N. J. Donato (2010)
Cancer Res.
70, 9265-9276
|Abstract »|Full Text »|PDF »
Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense.
K.-i. Arimoto, K. Funami, Y. Saeki, K. Tanaka, K. Okawa, O. Takeuchi, S. Akira, Y. Murakami, and K. Shimotohno (2010)
PNAS
107, 15856-15861
|Abstract »|Full Text »|PDF »
Identification of a Novel in Vivo Virus-targeted Phosphorylation Site in Interferon Regulatory Factor-3 (IRF3).
B. Bergstroem, I. B. Johnsen, T. T. Nguyen, L. Hagen, G. Slupphaug, L. Thommesen, and M. W. Anthonsen (2010)
J. Biol. Chem.
285, 24904-24914
|Abstract »|Full Text »|PDF »
The A20 Deubiquitinase Activity Negatively Regulates LMP1 Activation of IRF7.
Positive Regulation of Interferon Regulatory Factor 3 Activation by Herc5 via ISG15 Modification.
H. X. Shi, K. Yang, X. Liu, X. Y. Liu, B. Wei, Y. F. Shan, L. H. Zhu, and C. Wang (2010)
Mol. Cell. Biol.
30, 2424-2436
|Abstract »|Full Text »|PDF »
TAX1BP1 and A20 Inhibit Antiviral Signaling by Targeting TBK1-IKKi Kinases.
K. Parvatiyar, G. N. Barber, and E. W. Harhaj (2010)
J. Biol. Chem.
285, 14999-15009
|Abstract »|Full Text »|PDF »
Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases.
M. A. Clementz, Z. Chen, B. S. Banach, Y. Wang, L. Sun, K. Ratia, Y. M. Baez-Santos, J. Wang, J. Takayama, A. K. Ghosh, et al. (2010)
J. Virol.
84, 4619-4629
|Abstract »|Full Text »|PDF »
Regulation of Virus-triggered Signaling by OTUB1- and OTUB2-mediated Deubiquitination of TRAF3 and TRAF6.
S. Li, H. Zheng, A.-P. Mao, B. Zhong, Y. Li, Y. Liu, Y. Gao, Y. Ran, P. Tien, and H.-B. Shu (2010)
J. Biol. Chem.
285, 4291-4297
|Abstract »|Full Text »|PDF »
Lysine 63 Polyubiquitination in Immunotherapy and in Cancer-promoting Inflammation.
I. Martinez-Forero, A. Rouzaut, A. Palazon, J. Dubrot, and I. Melero (2009)
Clin. Cancer Res.
15, 6751-6757
|Abstract »|Full Text »|PDF »
Polo-like Kinase 1 (PLK1) Regulates Interferon (IFN) Induction by MAVS.
D. Vitour, S. Dabo, M. Ahmadi Pour, M. Vilasco, P.-O. Vidalain, Y. Jacob, M. Mezel-Lemoine, S. Paz, M. Arguello, R. Lin, et al. (2009)
J. Biol. Chem.
284, 21797-21809
|Abstract »|Full Text »|PDF »
MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK2.
J. Hou, P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao (2009)
J. Immunol.
183, 2150-2158
|Abstract »|Full Text »|PDF »
I. B. Johnsen, T. T. Nguyen, B. Bergstroem, K. A. Fitzgerald, and M. W. Anthonsen (2009)
J. Biol. Chem.
284, 19122-19131
|Abstract »|Full Text »|PDF »
Ubiquitin-Regulated Recruitment of I{kappa}B Kinase {varepsilon} to the MAVS Interferon Signaling Adapter.
S. Paz, M. Vilasco, M. Arguello, Q. Sun, J. Lacoste, T. L.-A. Nguyen, T. Zhao, E. A. Shestakova, S. Zaari, A. Bibeau-Poirier, et al. (2009)
Mol. Cell. Biol.
29, 3401-3412
|Abstract »|Full Text »|PDF »
Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer.
J. M. Zapata, D. Llobet, M. Krajewska, S. Lefebvre, C. L. Kress, and J. C. Reed (2009)
Blood
113, 4595-4603
|Abstract »|Full Text »|PDF »
Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine.
K. Breckpot, C. Aerts-Toegaert, C. Heirman, U. Peeters, R. Beyaert, J. L. Aerts, and K. Thielemans (2009)
J. Immunol.
182, 860-870
|Abstract »|Full Text »|PDF »
Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-{beta} Induction during the Early Phase of Viral Infection.
H. Oshiumi, M. Matsumoto, S. Hatakeyama, and T. Seya (2009)
J. Biol. Chem.
284, 807-817
|Abstract »|Full Text »|PDF »
FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway.
T. Sanada, G. Takaesu, R. Mashima, R. Yoshida, T. Kobayashi, and A. Yoshimura (2008)
J. Biol. Chem.
283, 33858-33864
|Abstract »|Full Text »|PDF »
Proteases: Multifunctional Enzymes in Life and Disease.
C. Lopez-Otin and J. S. Bond (2008)
J. Biol. Chem.
283, 30433-30437
|Full Text »|PDF »
TRAF6 and the Three C-Terminal Lysine Sites on IRF7 Are Required for Its Ubiquitination-Mediated Activation by the Tumor Necrosis Factor Receptor Family Member Latent Membrane Protein 1.
S. Ning, A. D. Campos, B. G. Darnay, G. L. Bentz, and J. S. Pagano (2008)
Mol. Cell. Biol.
28, 6536-6546
|Abstract »|Full Text »|PDF »
The Deubiquitinating Enzyme Ataxin-3, a Polyglutamine Disease Protein, Edits Lys63 Linkages in Mixed Linkage Ubiquitin Chains.
B. J. Winborn, S. M. Travis, S. V. Todi, K. M. Scaglione, P. Xu, A. J. Williams, R. E. Cohen, J. Peng, and H. L. Paulson (2008)
J. Biol. Chem.
283, 26436-26443
|Abstract »|Full Text »|PDF »
The NY-1 Hantavirus Gn Cytoplasmic Tail Coprecipitates TRAF3 and Inhibits Cellular Interferon Responses by Disrupting TBK1-TRAF3 Complex Formation.
P. J. Alff, N. Sen, E. Gorbunova, I. N. Gavrilovskaya, and E. R. Mackow (2008)
J. Virol.
82, 9115-9122
|Abstract »|Full Text »|PDF »
Regulation of I{kappa}B Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD.
M. Zhang, X. Wu, A. J. Lee, W. Jin, M. Chang, A. Wright, T. Imaizumi, and S.-C. Sun (2008)
J. Biol. Chem.
283, 18621-18626
|Abstract »|Full Text »|PDF »
Homo-oligomerization Is Essential for Toll/Interleukin-1 Receptor Domain-containing Adaptor Molecule-1-mediated NF-{kappa}B and Interferon Regulatory Factor-3 Activation.
K. Funami, M. Sasai, H. Oshiumi, T. Seya, and M. Matsumoto (2008)
J. Biol. Chem.
283, 18283-18291
|Abstract »|Full Text »|PDF »